April 3, 2018 / 5:06 AM / 6 months ago

BRIEF-‍European Commission Approves Expanded Indication For Amgen's Xgeva

April 3 (Reuters) - Amgen Inc:

* ‍EUROPEAN COMMISSION APPROVES EXPANDED INDICATION FOR AMGEN’S XGEVA (DENOSUMAB) FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below